- Home
- BMRC vs BNTC Comparison
BMRC vs BNTC Comparison
Compare BMRC & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRC
- BNTC
- Stock Information
- Founded
- BMRC 1989
- BNTC 1995
- Country
- BMRC United States
- BNTC United States
- Employees
- BMRC N/A
- BNTC N/A
- Industry
- BMRC Major Banks
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- BMRC Finance
- BNTC Health Care
- Exchange
- BMRC Nasdaq
- BNTC Nasdaq
- Market Cap
- BMRC 394.5M
- BNTC 339.8M
- IPO Year
- BMRC N/A
- BNTC N/A
- Fundamental
- Price
- BMRC $22.12
- BNTC $12.55
- Analyst Decision
- BMRC Strong Buy
- BNTC Strong Buy
- Analyst Count
- BMRC 3
- BNTC 7
- Target Price
- BMRC $28.00
- BNTC $24.43
- AVG Volume (30 Days)
- BMRC 64.0K
- BNTC 61.5K
- Earning Date
- BMRC 04-28-2025
- BNTC 05-12-2025
- Dividend Yield
- BMRC 4.50%
- BNTC N/A
- EPS Growth
- BMRC N/A
- BNTC N/A
- EPS
- BMRC N/A
- BNTC N/A
- Revenue
- BMRC $67,983,000.00
- BNTC N/A
- Revenue This Year
- BMRC $63.26
- BNTC N/A
- Revenue Next Year
- BMRC $9.68
- BNTC N/A
- P/E Ratio
- BMRC N/A
- BNTC N/A
- Revenue Growth
- BMRC N/A
- BNTC N/A
- 52 Week Low
- BMRC $14.11
- BNTC $4.75
- 52 Week High
- BMRC $27.11
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- BMRC 39.77
- BNTC 44.19
- Support Level
- BMRC $21.51
- BNTC $11.54
- Resistance Level
- BMRC $22.94
- BNTC $15.08
- Average True Range (ATR)
- BMRC 0.83
- BNTC 1.26
- MACD
- BMRC 0.01
- BNTC -0.43
- Stochastic Oscillator
- BMRC 22.34
- BNTC 18.84
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties, and others. The majority of its revenue comes from interest income.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.